<DOC>
	<DOCNO>NCT00451620</DOCNO>
	<brief_summary>The result DECODE Study show postprandial ( 1 - 2 hour meal ) hyperglycemia ( elevate blood sugar ) common elderly people diabetes young people diabetes best predictor development complication . The DECODE Study involve 6941 people already diabetes 702 diabetes . Diabetes diagnose blood sugar 1st thing morning 7.0 mmol/L . The DECODE Study show people risk diabetes normal blood sugar 1st thing morning high blood sugar 2 hour meal people risk develop heart disease complication diabetes . These people would identify risk fast blood sugar do . Studies young people diabetes show meal , insulin level like person without diabetes glucose ( blood sugar ) level low GlucoNorm Glyburide . There data available demonstrates elderly people type 2 diabetes . You invited participate study type 2 diabetes control diet and/or exercise metformin 65 year age . The purpose study determine whether GlucoNorm great effect Glyburide insulin level glucose ( blood sugar ) level meal elderly people type 2 diabetes control diabetes diet exercise .</brief_summary>
	<brief_title>Effect GlucoNorm v Glyburide Post-Prandial Hyperglycemia Elderly Subjects With Type 2 Diabetes</brief_title>
	<detailed_description>The result DECODE Study show postprandial hyperglycemia common elderly people diabetes young people best predictor mortality morbidity . Studies young people diabetes show response meal , insulin profile physiologic glucose level low GlucoNorm Glyburide . There data available demonstrates elderly people type 2 diabetes . This randomized , open-label , cross-over study . Subjects undergo 2 Standard Meal Tests Ensure 325 ml separate 15 - 30 day . Group 1 receive GlucoNorm 1 mg 1st Standard Meal Test Glyburide 2.5 mg 2nd Standard Meal Test . Group 2 receive Glyburide 2.5 mg 1st Standard Meal Test GlucoNorm 1mg 2nd Standard Meal Test .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Type 2 diabetes &gt; 3 month duration Male female Over 65 year age Diet control HgbA1C &lt; 8.5 % Treatment oral hypoglycemic agent insulin likelihood require treatment study . Anemia hgb 130 g/L ( male ) 120 g/L ( female ) . Taking medication know interfere glucose metabolism eg systemic corticosteriods , nonselective beta blocker . Known suspect allergy glyburide , sulfa drug GlucoNorm impair liver function , show limited AST and/or ALT &gt; 2x upper limit normal . Impaired renal function , show limited serum creatinine &gt; 133 µmol/L ( male ) 124 µmol/L ( female ) . Participated another clinical trial within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Oral hypoglycemic agent</keyword>
	<keyword>Insulin level</keyword>
</DOC>